Previous Versions of this Report
Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End User (Pediatric, Adult) & Region - Global Forecast to 2026
Report Code
PH 6528
Published in
Nov, 2023, By MarketsandMarkets™
Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End user (Pediatric, Adult) - Global Forecast to 2026
Report Code
PH 6528
Published in
Jan, 2022, By MarketsandMarkets™
Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, shingles, Rabies), Route (IM, SC, ID, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2024
Report Code
PH 6528
Published in
Jan, 2020, By MarketsandMarkets™
Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023
Report Code
PH 6528
Published in
Aug, 2018, By MarketsandMarkets™
Vaccine Market by Technology (Live, Conjugate, Toxoid, Recombinant), Disease (Influenza, DTaP, HPV, Hepatitis, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, Rabies), Route (IM, SC, ID, Oral), End User (Pediatric, Adult) & Type - Forecast to 2022
Report Code
BT 3113
Published in
Aug, 2017, By MarketsandMarkets™
Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021
Report Code
BT 3113
Published in
Aug, 2016, By MarketsandMarkets™
Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019
Report Code
BT 3113
Published in
Feb, 2015, By MarketsandMarkets™
Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019
Report Code
BT 3113
Published in
Jul, 2013, By MarketsandMarkets™
Frederick
May, 2022
What are the growing opportunities in Vaccines Market Size, Share, Growth, Covid-19 Impact Analysis, forecasts to 2028 ?.
Ross
Dec, 2022
Which are some of the significant growth strategies adopted by leading companies in this market?.
Harry
Dec, 2022
According to this report which are the top 3 companies operating in the global vaccine market?.
Ralph
Mar, 2022
How the Asia Pacific region in the Global Vaccines Market is Expecting a Highest Growth Rate During the Forecast Period?.
Eugene
Mar, 2022
Which end user segment holds the largest share of the Global Vaccines Market?.